BGF (formerly Business Growth Fund) is a London-based private equity and growth capital firm established in 2011, providing patient, minority equity investment to small and mid-sized businesses across the UK and Ireland. It has deployed more than £4.5bn of growth capital and is a certified B Corporation.
Deal activity decreased year-over-year (6 deals in the last 12 months vs 11 prior). Average disclosed round size is $30.7M (across 79 rounds with reported amounts).
Portfolio
170
Fund Size
—
Top Stage
Unknown
Last 12 Mo
6
Team
Anita Dougall
Non-Executive Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
229 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| RRedfaire | Growth | — | Aug 2026 |
 Everflow | Unknown | $59M | Jul 2026 |
| EEverflow | Unknown | $59M | Jul 2026 |
 Luffy AI | Series A | — | Jul 2026 |
| FFivium | Unknown | — | Apr 2026 |
| RRedfaire | Unknown | — | Jan 2026 |
 Fluidic | Series A | $31M | Jan 2026 |
 Open Cosmos | Series C | $348M | Jan 2026 |
| TTMT ID | Growth | — | Nov 2025 |
| EEnhanced Genomics | Series A | — | Sep 2025 |
| CCyted Health | Series B | $44M | Sep 2025 |
 Cronofy | Growth | $19.1M | May 2025 |
| PPhlux Technology | Series A | $10.7M | Mar 2025 |
| MMaxion Therapeutics Ltd. | Series A | $72M | Mar 2025 |
 TRIMTECH Therapeutics | Seed | $14M | Mar 2025 |
 Cambridge GaN Devices | Series C | — | Feb 2025 |
 OrganOx | Unknown | $142M | Jan 2025 |
 Maxion | Series A | $72M | Jan 2025 |
 Cellular Origins | Series A | $40M | Jan 2025 |
 Cyted | Series B | $44M | Jan 2025 |
| MMaxion Therapeutics Ltd. | Series A | $72M | Jan 2025 |
| CCyted Health | Unknown | $44M | Jan 2025 |
 T-Therapeutics | Series A | $32M | Jan 2025 |
 Sulmara | Growth | — | Nov 2024 |
 DEScycle | Series A | — | Nov 2024 |
Page 1 of 10
Top Co-Investors
Parkwalk Advisors17 shared
Octopus Ventures17 shared
Eli Lilly and Company8 shared
Barclays8 shared
Nauta Capital8 shared
British Business Bank7 shared
Amadeus Capital Partners6 shared
Foresight Ventures6 shared
General Catalyst6 shared
British Patient Capital6 shared
Cambridge Enterprise6 shared
Cambridge Angels6 shared
Gresham House5 shared
Morningside5 shared
Kindred Ventures5 shared
Phoenix Court Group5 shared
LifeArc Ventures5 shared
UCL Technology Fund5 shared
IQ Capital5 shared
Last updated: 20 October 2026